Literature DB >> 16825118

Structural changes in the fibrin network of a pretoria family with dysfibrinogenemia: a scanning electron microscopical study.

E Pretorius1, S Briedenhann, J Marx, R C Franz.   

Abstract

Inborn errors of fibrinogen structure are by definition congenital dysfibrinogenemias. The present study assesses the scanning electron microscope characteristics in the fibrin network morphology in a Pretoria family with an amino-acid substitution defect at position 139 on the gamma chain where the cystein residue is replaced by tyrosine. This anomaly results in a disturbance of the interchain disulfide bond, an ultrastructural defect that interferes with fibrin polymerization. Clinical manifestations showed that 2 of the family members presented with thrombosis, as well as a bleeding tendency, while 2 were asymptomatic. Fibrin clot analysis revealed that in all 4 family members a tighter fibrin network with increased fibrin density and reduced pore size was present. The fibers showed a "stellate" appearance where they converge and some were fused longitudinally to form sheets of "matted" fibrin. Furthermore, there was a conspicuous absence of platelets. Fibrin dysfunction is associated with the development of vascular complications, while proneness to the formation of tight and rigid fibrin networks is independently associated with thrombotic disease. Although this does not explain the proneness of some family members who present with excess bleeding, bleeding might be related to the defective binding of fibrin to activated platelets, resulting in inadequate prothrombotic stimulus that is normally enhanced by the second wave of thrombin generation, which occurs on the platelet surface.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825118     DOI: 10.1080/01913120600689772

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  5 in total

1.  Ultrathin self-assembled fibrin sheets.

Authors:  E Tim O'Brien; Michael R Falvo; Daniel Millard; Brian Eastwood; Russell M Taylor; Richard Superfine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

2.  Could tiny blood clots cause long COVID's puzzling symptoms?

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2022-08       Impact factor: 69.504

3.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

Review 4.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.

Authors:  Douglas B Kell; Gert Jacobus Laubscher; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

5.  Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach.

Authors:  Etheresia Pretorius; Janette Bester
Journal:  Oncotarget       Date:  2016-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.